Fig 1.
Distribution of the 1500 participants selected from the Korea National Health and Nutrition Examination Survey, 2014 to 2015 according to region (A), and age and sex (B). Gyeonggi, Gyeonggi-do; Gangwon, Gangwon-do; Chungbuk, Chungcheongbuk-do; Chungnam, Chungcheongnam-do; Jeonbuk, Jeollabuk-do; Jeonnam, Jeollanam-do; Gyeongbuk, Gyeongsangbuk-do; Gyeongnam, Gyeongsangnam-do; Jeju, Jeju-do.
Table 1.
SFTS seropositivity determined by IFA in samples collected from the Korea National Health and Nutrition Examination Survey, 2014 to 2015.
Fig 2.
Number of severe fever with thrombocytopenia syndrome (SFTS) patients reported in Infectious Disease Portal of Korea Disease Control and Prevention Agency according to region and incidence per 100,000 between 2014 and 2015.
Fig 3.
Regional incidence of severe fever with thrombocytopenia syndrome (SFTS) per 100,000 individuals for each of the 16 cities and provinces, and immunoglobulin (Ig) G antibody positivity rate.
A. Choropleth map showing national SFTS seroprevalence (%) with IgG titer of ≥ 1:32. Choropleth map was amended using base map obtained from “Editable South Korea Map Template For Presentation” (https://www.slideegg.com/powerpoint/south-korea-map-powerpoint-templates). B. Plot showing regional SFTS incidence per 100,000 individuals and IgG positivity rate (titer ≥ 1:32, ≥ 1:64).
Fig 4.
Correlation of the number of severe fever with thrombocytopenia syndrome (SFTS) patients (left) and SFTS incidence per 100,000 (right) with IgG antibody positivity rates (IgG titer, ≥ 1:32, A; IgG titer ≥ 1:64, B) between 2014 and 2015.
Table 2.
SFTS seropositivity and epidemiological characteristics of the 1500 participants selected from the Korea National Health and Nutrition Examination Survey, 2014 to 2015.
Table 3.
SFTS seropositivity according to underlying diseases, influenza vaccination, economic activity, and occupational characteristics of the 1500 participants selected from the Korea National Health and Nutrition Examination Survey, 2014 to 2015.